EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alternate day fasting aggravates atherosclerosis through the suppression of hepatic ATF3 in Apoe−/− mice

Yajuan Deng, Xiaoyu Yang, Xueru Ye, Youwen Yuan, Yanan Zhang, Fei Teng, Danming You, Xuan Zhou, Wenhui Liu, Kangli Li, Shenjian Luo, Zhi Yang und 4 weitere

Life Metabolism · 01.06.2024 · 3 (3)

DOI: 10.1093/lifemeta/loae009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Metabolism, online erschienen am 07.03.2024. Verfasst von Yajuan Deng und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, National Key Research and Development Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is the major contributor to cardiovascular mortality worldwide. Alternate day fasting (ADF) has gained growing attention due to its metabolic benefits. However, the effects of ADF on atherosclerotic plaque formation remain inconsistent and controversial in atherosclerotic animal models. The present study was designed to investigate the effects of ADF on atherosclerosis in apolipoprotein E-deficient (Apoe−/−) mice. Eleven-week-old male Apoe−/− mice fed with Western diet (WD) were randomly grouped into ad libitum (AL) group and ADF group, and ADF aggravated both the early and advanced atherosclerotic lesion formation, which might be due to the disturbed cholesterol profiles caused by ADF intervention. ADF significantly altered cholesterol metabolism pathways and down-regulated integrated stress response (ISR) in the liver. The hepatic expression of activating transcription factor 3 (ATF3) was suppressed in mice treated with ADF and hepatocyte-specific overexpression of Aft3 attenuated the effects of ADF on atherosclerotic plaque formation in Apoe−/− mice. Moreover, the expression of ATF3 could be regulated by Krüppel-like factor 6 (KLF6) and both the expressions of ATF3 and KLF6 were regulated by hepatic cellular ISR pathway. In conclusion, ADF aggravates atherosclerosis progression in Apoe−/− mice fed on WD. ADF inhibits the hepatic ISR signaling pathway and decreases the expression of KLF6, subsequently inhibiting ATF3 expression. The suppressed ATF3 expression in the liver mediates the deteriorated effects of ADF on atherosclerosis in Apoe−/− mice. The findings suggest the potentially harmful effects when ADF intervention is applied to the population at high risk of atherosclerosis.

Schlagwörter

Stichwörter der Autor:innen

activating transcription factor 3alternate day fastingatherosclerosischolesterolintegrated stress response

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • Department of Endocrinology and Metabolism, Guangdong Provincial Key Laboratory of Diabetology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China.
  • Department of Endocrinology, The Second Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi 030001, China.
  • Guangdong Provincial Key Laboratory of Shock and Microcirculation, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.
  • State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China.

ORCID-Profile: Huijie Zhang

Förderung

  • National Science Fund for Distinguished Young Scholars
  • National Natural Science Foundation of China
  • National Key Research and Development Project
  • Southern Medical University

Zitieren

APA

Deng, Y., Yang, X., Ye, X., Yuan, Y., Zhang, Y., Teng, F., You, D., Zhou, X., Liu, W., Li, K., Luo, S., Yang, Z., Chen, R., Shi, G., Li, J., & Zhang, H. (2024). Alternate day fasting aggravates atherosclerosis through the suppression of hepatic ATF3 in Apoe−/− mice. Life Metabolism, 3(3). https://doi.org/10.1093/lifemeta/loae009

Vancouver

Deng Y, Yang X, Ye X, Yuan Y, Zhang Y, Teng F, et al. Alternate day fasting aggravates atherosclerosis through the suppression of hepatic ATF3 in Apoe−/− mice. Life Metabolism. 2024;3(3). doi:10.1093/lifemeta/loae009

BibTeX
@article{Deng2024,
  author = {Deng, Yajuan and Yang, Xiaoyu and Ye, Xueru and Yuan, Youwen and Zhang, Yanan and Teng, Fei and You, Danming and Zhou, Xuan and Liu, Wenhui and Li, Kangli and Luo, Shenjian and Yang, Zhi and Chen, Ruxin and Shi, Guojun and Li, Jin and Zhang, Huijie},
  title = {Alternate day fasting aggravates atherosclerosis through the suppression of hepatic ATF3 in Apoe−/− mice},
  journal = {Life Metabolism},
  year = {2024},
  volume = {3},
  number = {3},
  doi = {10.1093/lifemeta/loae009}
}
Kostenlos starten →